He Got A Rare Disease Diagnosis So He Rethought The Whole System (Worth)
While working to understand not only his own rare disease but also how the broader healthcare industry develops treatments for rare diseases as a whole, Onno Faber uncovered the building blocks of his new company.
Read the full article on Worth:
3,700 disease-causing genes: Our plan to fill the void in rare disease drug discovery
Rarebase Remarks Episode #4 - Clayton Mellina: Engineering and AI in the biotech space
Rarebase launches a neuroscience drug discovery platform collaborating with 15 rare disease patient organizations